{'fraction_non_alphanumeric': 0.023991275899672846, 'fraction_numerical': 0.010905125408942203, 'mean_word_length': 5.3310344827586205, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
ESC/EASD guideline sheds light on diabetes and cardiovascular disease management

Just as the number of people with, or at risk of developing, diabetes grows inexorably, so it seems does the volume of clinical research on diabetes management. Clinicians who wonder how they will get to grips with all this information will welcome the third guideline on managing cardiovascular disease (CVD) in people with diabetes and prediabetes from the European Society of Cardiology (ESC), which it developed in collaboration with the European Association for the Study of Diabetes (EASD).1 The 58-page document summarises and interprets key evidence published since the 2013 version, presenting its recommendations in clear, colour-coded tables. This is supported by no fewer than 579 references, and online resources will ultimately include a slide set, a pocket version, an app and questions for continuing medical education.